Publikationen, an denen er mitarbeitet Jaume Sauleda Roig (12)

2022

  1. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 135-141

2020

  1. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 5, pp. 453-460

2018

  1. Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis

    Expert Review of Respiratory Medicine

2015

  1. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation

    BMC Pulmonary Medicine, Vol. 15, Núm. 1

2014

  1. Determinants of exercise capacity in obese and non-obese COPD patients

    Respiratory Medicine, Vol. 108, Núm. 5, pp. 745-751

  2. Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients

    PLoS ONE, Vol. 9, Núm. 2

2012

  1. Consensus Document on the Overlap Phenotype COPD-Asthma in COPD

    Archivos de Bronconeumologia, Vol. 48, Núm. 9, pp. 331-337

  2. Cured meat consumption increases risk of readmission in COPD patients

    European Respiratory Journal, Vol. 40, Núm. 3, pp. 555-560

  3. Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae

    Respiratory Research, Vol. 13

2011

  1. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

    Thorax, Vol. 66, Núm. 5, pp. 430-437

2009

  1. La heterogeneidad fenotípica de la EPOC

    Archivos de Bronconeumologia, Vol. 45, Núm. 3, pp. 129-138

  2. Physical activity and clinical and functional status in COPD

    Chest, Vol. 136, Núm. 1, pp. 62-70